In an analysis of data obtained from the NASH clinical research network, among 1153 patients with biopsy-proven NAFLD, researchers determined that ADH1B*2 reduced the risk of NASH and fibrosis in adults with NAFLD, regardless of their alcohol consumption status [4]. Here, ADH1B is linked to metabolic dysfunction-associated steatohepatitis.